Pharm-Olam Opens Third Office in Russia

Friday, May 23, 2008 01:20 PM

Houston, Texas-based CRO Pharm-Olam International, along with its sister-company MB Quest, opened a new office in St. Petersburg, Russia. The office is Pharm-Olam’s third location in the country to date, after expanding into Moscow and Novosibirsk. The new office is set to house 20 clinical staff by the fourth quarter of 2008. The company stated it has been conducting studies in Russia since 1997, but was using regional employees to monitor trials in St. Petersburg. 

“Because of the concentration of state-approved sites for research and the continued interest from sponsors, it made sense to establish a permanent office there,” said Eugene Barg, president of MBQ.

Like Pharm-Olam, MB Quest is a subsidiary of the POI Group.  It operates in Russia, Ukraine, Georgia, and Belarus. It is also a founding member of the Association of Clinical Trial Organizations in Russia (ACTO). Pharm-Olam International Group now has 25 offices worldwide.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs